Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | RXRA | P19793 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.44 |
| ▸ | F7 | P08709 | 3/20 | 0.44 |
| ▸ | F3 | P13726 | 3/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
| ▸ | PPARA | Q07869 | 2/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13169080 | 0.89 | ADORA3 (0.43) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL13169167 | 0.86 | ALDH1A1 (0.51) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL14036955 | 0.82 | ADORA3 (0.47) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL13169168 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL3688839 | 0.80 | ADORA3 (0.38) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL13609252 | 0.79 | TSHR (0.55) | ALDH1A1MAPTKMT2ACYP3A4TDP1 | |
| SCHEMBL3691603 | 0.77 | PRKCA (0.38) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL14036961 | 0.75 | ADORA3 (0.35) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL3695677 | 0.74 | ADORA3 (0.34) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL4557650 | 0.73 | ATM (0.40) | ALDH1A1ADORA3NR1I2PTGS2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| WO-2008132552-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | ELOVL3, FFAR3, STARD3 | ALDH1A1 2317/4885CYP19A1 1573/4885OXER1 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.